🇮🇹 PAZOPANIB in Italy

PAZOPANIB (PAZOPANIB) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Votrient
  • Status: approved

PAZOPANIB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PAZOPANIB approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for PAZOPANIB in Italy?

Marketing authorisation holder not available in our data.